Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
78.90
-2.60 (-3.19%)
Jul 29, 2026, 1:30 PM CST

Gongwin Biopharm Holdings Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
38.2836.4532.0418.921.141.14
Revenue Growth
11.86%13.75%69.39%1554.86%0%37.21%
Gross Profit
27.126.098.6811.21.071.08
Operating Income
-223.6-207.29-162.06-133.33-260.68-120.83
Net Income
-142.02-114.13-82.55-92.04-292.13-121.58
Earnings Per Share
-1.16-0.92-0.68-0.81-2.63-1.11
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Hong Kong and Mainland China
35.0731.9318.92--
Taiwan
1.38--1.141.14
Singapore
-0.11---
Total
36.4532.0418.921.141.14

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,5391,6662,209942.251,106826.33
Total Debt
139.09129.74126.7577.17141.74115.14
Net Cash (Debt)
1,4001,5362,082865.08963.87711.19
Net Cash Growth
-25.78%-26.22%140.73%-10.25%35.53%-29.07%
Net Cash Per Share
11.4112.4517.247.648.676.49

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-152.67-135.75-87.41-110.8-232.2-95.51
Capital Expenditures
-1.09-1.86-205.89-0.91-7.34-123.01
Free Cash Flow
-153.76-137.62-293.3-111.7-239.54-218.52
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.78%71.58%27.09%59.21%93.26%94.31%
Operating Margin
-584.07%-568.76%-505.80%-704.87%-22806.74%-10570.95%
Pretax Margin
-389.55%-331.64%-286.69%-534.89%-25558.44%-10036.75%
Profit Margin
-370.96%-313.14%-257.64%-486.58%-25558.44%-10637.01%
FCF Margin
-401.63%-377.59%-915.41%-590.55%-20956.69%-19118.11%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
249.80289.68448.481105.5031611.2427212.59